{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:43:09Z","timestamp":1787013789814,"version":"build-2736575974"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R03DA038084"],"award-info":[{"award-number":["1R03DA038084"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To describe characteristics of participants and overdose reversals associated with a community\u2010based naloxone distribution program and identify predictors of obtaining naloxone refills and using naloxone for overdose reversal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Bivariate statistical tests were used to compare characteristics of participants who obtained refills and reported overdose reversals versus those who did not. We fitted multiple logistic regression models to identify predictors of refills and reversals; zero\u2010inflated multiple Poisson regression models were used to identify predictors of number of refills and reversals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>San Francisco, California, USA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Naloxone program participants registered and reversals reported from 2010 to 2013.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Baseline characteristics of participants and reported characteristics of reversals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>A total of 2500 participants were registered and 702 reversals were reported from 2010 to 2013. Participants who had witnessed an overdose [adjusted odds ratio (AOR)\u2009=\u20092.02, 95% confidence interval (CI)\u2009=\u20091.53\u20132.66; AOR\u2009=\u20092.73, 95% CI\u2009=\u20091.73\u20134.30] or used heroin (AOR\u2009=\u20091.85, 95% CI\u2009=\u2009 1.44\u20132.37; AOR\u2009=\u20092.19, 95% CI\u2009=\u20091.54\u20133.13) or methamphetamine (AOR\u2009=\u20091.71, 95% CI\u2009=\u20091.37\u20132.15; AOR\u2009=\u20091.61, 95% CI\u2009=\u20091.18\u20132.19) had higher odds of obtaining a refill and reporting a reversal, respectively. African American (AOR\u2009=\u20090.63, 95% CI\u2009=\u20090.45\u20130.88) and Latino (AOR\u2009=\u20090.65, 95% CI\u2009=\u2009 0.43\u20131.00) participants had lower odds of obtaining a naloxone refill, whereas Latino participants who obtained at least one refill reported a higher number of refills [incidence rate ratio (IRR)\u2009=\u20091.33 (1.05\u20131.69)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Community naloxone distribution programs are capable of reaching sizeable populations of high\u2010risk individuals and facilitating large numbers of overdose reversals. Community members most likely to engage with a naloxone program and use naloxone to reverse an overdose are active drug users.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.12961","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T06:36:09Z","timestamp":1430116569000},"page":"1301-1310","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Predictors of participant engagement and naloxone utilization in a community\u2010based naloxone distribution program"],"prefix":"10.1111","volume":"110","author":[{"given":"Christopher","family":"Rowe","sequence":"first","affiliation":[{"name":"University of California, Berkeley, School of Public Health Division of Epidemiology  Berkeley CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn\u2010Milo","family":"Santos","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health  San Francisco CA USA"},{"name":"University of California, San Francisco  San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[{"name":"University of California, San Francisco  San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Drug Overdose Prevention and Education Project, Harm Reduction Coalition  Oakland CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Davidson","sequence":"additional","affiliation":[{"name":"University of California, San Diego  La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip O.","family":"Coffin","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health  San Francisco CA USA"},{"name":"University of California, San Francisco  San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"e_1_2_6_3_1","volume-title":"Prescription Drug Overdose","author":"Centers for Disease Control and Prevention (CDC)","year":"2014"},{"key":"e_1_2_6_4_1","volume-title":"Policy Impact: Prescription Painkiller Overdoses","author":"Centers for Disease Control and Prevention (CDC)","year":"2014"},{"key":"e_1_2_6_5_1","first-page":"1","volume-title":"National Center for Health Statistics (NCHS) data brief","author":"Warner M.","year":"2011"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.11.018"},{"key":"e_1_2_6_7_1","first-page":"101","article-title":"Community\u2010based opioid overdose prevention programs providing naloxone\u2014United States, 2010","volume":"61","author":"Centers for Disease C., Prevention","year":"2012","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12035"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-1-201301010-00003"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000034"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(94)90033-7"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181c38c25"},{"key":"e_1_2_6_13_1","volume-title":"WHO Model List of Essential Medicines","author":"World Health Organization (WHO)","year":"2013"},{"key":"e_1_2_6_14_1","volume-title":"Consolidated Guidelines on HIV Prevention, Treatment and Care for Key Populations","author":"World Health Organization (WHO)","year":"2014"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2006.05.025"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n03_11"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2008.146647"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-010-9495-8"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-011-9600-7"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-9-201311050-00005"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2007.tb01846.x"},{"key":"e_1_2_6_23_1","first-page":"1","volume-title":"National Center for Health Statistics (NCHS) data brief","author":"Warner M.","year":"2009"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-010-9525-6"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.111.3.455"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470753552.ch4"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.05.004"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9345157.x"},{"key":"e_1_2_6_29_1","unstructured":"HartA.Fiscal Year 2013\u20132014. Annual Report for FY 2010\u20132011. Office of the Chief Medical Examiner City and County of San Francisco: San Francisco CA;2013."},{"key":"e_1_2_6_30_1","volume-title":"State and County QuickFacts","author":"US Census Bureau","year":"2014"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg029"},{"key":"e_1_2_6_32_1","unstructured":"HartA.Annual Report for July 2002 to June 2003. Office of the Chief Medical Examiner City and County of San Francisco: San Francisco CA;2004."},{"key":"e_1_2_6_33_1","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA).Drug Abuse Warning Network 2011 Emergency Department Excel Files Metro Division San Francisco. In: Div_2011_AllMA S. S. editor. Rockville MD: Office of Applied Studies SAMHSA;2011."}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12961","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.12961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:18:24Z","timestamp":1696504704000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/add.12961"],"URL":"https:\/\/doi.org\/10.1111\/add.12961","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]},"assertion":[{"value":"2014-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}